Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ECARX Antora® and Cloupeak® Solutions Expand into UK with Launch of Geely EX5
-
T1 Energy Advances G2_Austin Development with Capital Formation Progress
-
Havila Kystruten AS: Notice of extraordinary general meeting November 7th, 2025
-
Scholars from China and abroad gather in Nanping, Fujian for cross-cultural dialogues on Zhu Xi's legacy
-
Scholars from China and abroad gather in Nanping, Fujian for cross-cultural dialogues on Zhu Xi's legacy
-
New Crypto Mutuum Finance (MUTM) Crosses $17.8 Million Raised as Holder Count Nears 17,500
-
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
-
Wright Flood Announces Agreement To Acquire Assets of Poulton Associates LLC
-
Parsons Awarded Seat On $10 Billion Ceiling Value U.S. Navy Integration and Logistics Support Contract
-
Toobit Reinforces Multi-Layered Security with SlowMist Full-Suite Testing
-
Lantern Finance Reports Zero Liquidations Amid $19 Billion Crypto Market Crash
-
LHV Group AS announces the passing of a Supervisory Board member
-
Profound Named to Redpoint Ventures’ Inaugural AI64 List of the Most Promising AI Companies
-
Profound Named to Redpoint Ventures’ Inaugural AI64 List of the Most Promising AI Companies Shaping the Future
-
MEDIA ADVISORY: Ontario Soccer’s 2025 Gary Miller Charity Shield Taking Place this Weekend
-
MEXC to Make Blockchain Life 2025 Debut as Diamond Sponsor in Dubai
-
Tri Pointe Homes Named to 2025 Fortune Best Workplaces for Women™ List for the Fourth Consecutive Year
-
Man Group PLC : Form 8.3 - Spectris plc
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
-
Southside Bancshares, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2025
-
Form 8.3 - Inspecs Group Plc
-
Hayati® Expands “Warm Night” Project to Support People Through Cold Season Across the UK
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PERSONAL FINAN - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
VEON to Release 3Q25 Earnings Update on November 10, 2025
-
PONY AI Inc. Reaches 300th Gen-7 BAIC Robotaxi Milestone, Advancing Toward 1,000-Vehicle Combined Fleet by Year-End
-
Viomi Technology Co., Ltd Announces Release of First Half 2025 Financial Results on November 10, 2025 and US$20 Million Share Repurchase Plan
-
GigaCloud Technology Inc Announces Planned Acquisition of New Classic Home Furnishings
-
Ress Life Investments A/S, Decisions of the extraordinary general meeting held on 24 October 2025
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Form 8.3 - [INSPECS GROUP PLC - Opening Disclosure - 23 10 2025] - (CGAML)
-
Form 8.3 - Unite Group plc
-
CoinEx Launches Fixed Savings: Enjoy Industry-Highest APYs with Stable Returns
-
Hesai Group to Report Third Quarter 2025 Financial Results on Tuesday, November 11, 2025
-
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
-
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
-
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
-
Vistin Pharma ASA: Invitation to Q3 2025 conference call
-
Release of Marimekko's Interim Report, 1 January–30 September 2025
-
Polpharma Group Announces Leadership Transition – Sebastian Szymanek appointed as its new President
-
Form 8.5 (EPT/RI)-PRS Reit PLC
-
Form 8.5 (EPT/RI)-Treatt plc
-
Form 8.5 (EPT/RI)-NCC Group plc
-
Form 8.5 (EPT/RI)-Inspecs Group PLC
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
AFARAK GROUP INVESTS IN PRODUCTION OF METALLURGICAL GRADE CHROME ORE CONCENTRATE
-
Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
-
Resolutions of the General Meeting of Shareholders of AB “Ignitis grupė”
-
Karolinska Development’s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D
